Moderna
MRNA
#1190
Rank
S$25.20 B
Marketcap
S$63.52
Share price
-0.77%
Change (1 day)
91.58%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of May 2026 (TTM): -141.19%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -141.19%. At the end of 2025 the company had an Operating Margin of -144.02%.

Operating Margin history for Moderna from 2018 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-144.02%27.73%
2024-112.75%93.19%
2023-58.37%-215.05%
202250.73%-32.28%
202174.90%-127.59%
2020-271.53%-74.69%
2019-1,072.92%241.94%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-124.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
27.89%-119.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
32.40%-122.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-118.00%-16.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-56.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,576.98% 1,016.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
8.70%-106.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
6.21%-104.40%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.